111 related articles for article (PubMed ID: 28420895)
1. The Downregulation of the Expression of CD147 by Tumor Suppressor REIC/Dkk-3, and Its Implication in Human Prostate Cancer Cell Growth Inhibition.
Mori A; Watanabe M; Sadahira T; Kobayashi Y; Ariyoshi Y; Ueki H; Wada K; Ochiai K; Li SA; Nasu Y
Acta Med Okayama; 2017 Apr; 71(2):135-142. PubMed ID: 28420895
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of REIC/Dkk-3 suppresses the expression of CD147 and inhibits the proliferation of human bladder cancer cells.
Horikawa Y; Watanabe M; Sadahira T; Ariyoshi Y; Kobayashi Y; Araki M; Wada K; Ochiai K; Li SA; Nasu Y
Oncol Lett; 2017 Sep; 14(3):3223-3228. PubMed ID: 28927069
[TBL] [Abstract][Full Text] [Related]
3. Promising therapeutic efficacy of a novel reduced expression in immortalized cells/dickkopf-3 expressing adenoviral vector for hepatocellular carcinoma.
Sawahara H; Shiraha H; Uchida D; Kato H; Kato R; Oyama A; Nagahara T; Iwamuro M; Horiguchi S; Tsutsumi K; Mandai M; Mimura T; Wada N; Takeuchi Y; Kuwaki K; Onishi H; Nakamura S; Watanabe M; Sakaguchi M; Takaki A; Nouso K; Yagi T; Nasu Y; Kumon H; Okada H
J Gastroenterol Hepatol; 2017 Oct; 32(10):1769-1777. PubMed ID: 28168749
[TBL] [Abstract][Full Text] [Related]
4. Preclinical biodistribution and safety study of reduced expression in immortalized cells/Dickkopf-3-encoding adenoviral vector for prostate cancer gene therapy.
Sugimoto M; Watanabe M; Kaku H; Li SA; Noguchi H; Ueki H; Sakaguchi M; Huh NH; Nasu Y; Kumon H
Oncol Rep; 2012 Nov; 28(5):1645-52. PubMed ID: 22941469
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of BiP/GRP78 sensitizes resistant prostate cancer cells to gene-therapeutic overexpression of REIC/Dkk-3.
Tanimoto R; Sakaguchi M; Abarzua F; Kataoka K; Kurose K; Murata H; Nasu Y; Kumon H; Huh NH
Int J Cancer; 2010 Apr; 126(7):1562-9. PubMed ID: 19626590
[TBL] [Abstract][Full Text] [Related]
6. Novel REIC/Dkk-3-encoding adenoviral vector as a promising therapeutic agent for pancreatic cancer.
Sawahara H; Shiraha H; Uchida D; Kato H; Nagahara T; Iwamuro M; Kataoka J; Horiguchi S; Watanabe M; Sakaguchi M; Takaki A; Nouso K; Nasu Y; Kumon H; Okada H
Cancer Gene Ther; 2016 Aug; 23(8):278-83. PubMed ID: 27468808
[TBL] [Abstract][Full Text] [Related]
7. REIC/Dkk-3-encoding adenoviral vector as a potentially effective therapeutic agent for bladder cancer.
Hirata T; Watanabe M; Kaku H; Kobayashi Y; Yamada H; Sakaguchi M; Takei K; Huh NH; Nasu Y; Kumon H
Int J Oncol; 2012 Aug; 41(2):559-64. PubMed ID: 22665039
[TBL] [Abstract][Full Text] [Related]
8. Adenovirus-mediated REIC/Dkk-3 gene transfer inhibits tumor growth and metastasis in an orthotopic prostate cancer model.
Edamura K; Nasu Y; Takaishi M; Kobayashi T; Abarzua F; Sakaguchi M; Kashiwakura Y; Ebara S; Saika T; Watanabe M; Huh NH; Kumon H
Cancer Gene Ther; 2007 Sep; 14(9):765-72. PubMed ID: 17599093
[TBL] [Abstract][Full Text] [Related]
9. Adenovirus-mediated overexpression of REIC/Dkk-3 selectively induces apoptosis in human prostate cancer cells through activation of c-Jun-NH2-kinase.
Abarzua F; Sakaguchi M; Takaishi M; Nasu Y; Kurose K; Ebara S; Miyazaki M; Namba M; Kumon H; Huh NH
Cancer Res; 2005 Nov; 65(21):9617-22. PubMed ID: 16266978
[TBL] [Abstract][Full Text] [Related]
10. Potential of adenovirus-mediated REIC/Dkk-3 gene therapy for use in the treatment of pancreatic cancer.
Uchida D; Shiraha H; Kato H; Nagahara T; Iwamuro M; Kataoka J; Horiguchi S; Watanabe M; Takaki A; Nouso K; Nasu Y; Yagi T; Kumon H; Yamamoto K
J Gastroenterol Hepatol; 2014 May; 29(5):973-83. PubMed ID: 24372695
[TBL] [Abstract][Full Text] [Related]
11. Preclinical safety and efficacy of in situ REIC/Dkk-3 gene therapy for prostate cancer.
Kawauchi K; Watanabe M; Kaku H; Huang P; Sasaki K; Sakaguchi M; Ochiai K; Huh NH; Nasu Y; Kumon H
Acta Med Okayama; 2012; 66(1):7-16. PubMed ID: 22358134
[TBL] [Abstract][Full Text] [Related]
12. Anti-cancer effects of REIC/Dkk-3-encoding adenoviral vector for the treatment of non-small cell lung cancer.
Shien K; Tanaka N; Watanabe M; Soh J; Sakaguchi M; Matsuo K; Yamamoto H; Furukawa M; Asano H; Tsukuda K; Nasu Y; Huh NH; Miyoshi S; Kumon H; Toyooka S
PLoS One; 2014; 9(2):e87900. PubMed ID: 24498395
[TBL] [Abstract][Full Text] [Related]
13. Partial sensitization of human bladder cancer cells to a gene-therapeutic adenovirus carrying REIC/Dkk-3 by downregulation of BRPK/PINK1.
Jin Y; Murata H; Sakaguchi M; Kataoka K; Watanabe M; Nasu Y; Kumon H; Huh NH
Oncol Rep; 2012 Mar; 27(3):695-9. PubMed ID: 22076283
[TBL] [Abstract][Full Text] [Related]
14. A super gene expression system enhances the anti-glioma effects of adenovirus-mediated REIC/Dkk-3 gene therapy.
Oka T; Kurozumi K; Shimazu Y; Ichikawa T; Ishida J; Otani Y; Shimizu T; Tomita Y; Sakaguchi M; Watanabe M; Nasu Y; Kumon H; Date I
Sci Rep; 2016 Sep; 6():33319. PubMed ID: 27625116
[TBL] [Abstract][Full Text] [Related]
15. Tumor suppressor REIC/DKK-3 and co-chaperone SGTA: Their interaction and roles in the androgen sensitivity.
Ochiai K; Morimatsu M; Kato Y; Ishiguro-Oonuma T; Udagawa C; Rungsuriyawiboon O; Azakami D; Michishita M; Ariyoshi Y; Ueki H; Nasu Y; Kumon H; Watanabe M; Omi T
Oncotarget; 2016 Jan; 7(3):3283-96. PubMed ID: 26658102
[TBL] [Abstract][Full Text] [Related]
16. REIC/Dkk-3 stable transfection reduces the malignant phenotype of mouse prostate cancer RM9 cells.
Chen J; Watanabe M; Huang P; Sakaguchi M; Ochiai K; Nasu Y; Ouchida M; Huh NH; Shimizu K; Kashiwakura Y; Kaku H; Kumon H
Int J Mol Med; 2009 Dec; 24(6):789-94. PubMed ID: 19885619
[TBL] [Abstract][Full Text] [Related]
17. REIC/Dkk-3 as a potential gene therapeutic agent against human testicular cancer.
Tanimoto R; Abarzua F; Sakaguchi M; Takaishi M; Nasu Y; Kumon H; Huh NH
Int J Mol Med; 2007 Mar; 19(3):363-8. PubMed ID: 17273781
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of inhibition of differentiation-1 via activation of activating transcription factor 3 and Smad regulates REIC/Dickkopf-3-induced apoptosis.
Kashiwakura Y; Ochiai K; Watanabe M; Abarzua F; Sakaguchi M; Takaoka M; Tanimoto R; Nasu Y; Huh NH; Kumon H
Cancer Res; 2008 Oct; 68(20):8333-41. PubMed ID: 18922905
[TBL] [Abstract][Full Text] [Related]
19. REIC/Dkk-3 overexpression downregulates P-glycoprotein in multidrug-resistant MCF7/ADR cells and induces apoptosis in breast cancer.
Kawasaki K; Watanabe M; Sakaguchi M; Ogasawara Y; Ochiai K; Nasu Y; Doihara H; Kashiwakura Y; Huh NH; Kumon H; Date H
Cancer Gene Ther; 2009 Jan; 16(1):65-72. PubMed ID: 18654608
[TBL] [Abstract][Full Text] [Related]
20. Integrin antagonist augments the therapeutic effect of adenovirus-mediated REIC/Dkk-3 gene therapy for malignant glioma.
Shimazu Y; Kurozumi K; Ichikawa T; Fujii K; Onishi M; Ishida J; Oka T; Watanabe M; Nasu Y; Kumon H; Date I
Gene Ther; 2015 Feb; 22(2):146-54. PubMed ID: 25394252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
